1. 014 Long-term effectiveness of natalizumab for RRMS: UK and global interim results from TYSABRI observational program. Issue 6 (27th May 2022) Authors: Nicholas, Richard; Harrower, Timothy; Su, Ray; Licata, Stephanie; Vonsy, Jean Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 023 Relapse outcomes with natalizumab Q4W vs switch to Q6W. Issue 6 (27th May 2022) Authors: Butzkueven, Helmut; Kappos, Ludwig; Spelman, Tim; Trojano, Maria; Wiendl, Heinz; Su, Ray; Hyde, Robert; Licata, Stephanie; Ho, Pei-Ran; Campbell, Nolan Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 085 Clinical outcomes were better for relapsing-remitting multiple sclerosis (RRMS) patients who remained on natalizumab compared to those who switched to oral or injectable therapies after 2 years in the tysabri® observational program (TOP). Issue 6 (24th May 2018) Authors: Butzkueven, Helmut; Kappos, Ludwig; Spelman, Tim; Trojano, Maria; Wiendl, Heinz; Dong, Qunming; Licata, Stephanie; Ho, Pei-Ran; Campbell, Nolan Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89:Issue 6(2018) Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 086 The rapid efficacy of natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): results from reveal, a randomised, head-to-head study. Issue 6 (24th May 2018) Authors: Butzkueven, Helmut; Jeffery, Douglas; Arnold, Douglas L; Filippi, Massimo; Geurts, Jeroen JG; Dong, Qunming; Campbell, Nolan; Licata, Stephanie; Ho, Pei-Ran Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89:Issue 6(2018) Page Start: A35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 194 Natalizumab treatment for MS: UK and global results from TOP. Issue 12 (14th November 2019) Authors: Nicholas, Richard; Harrower, Timothy; Jiang, Xiaoyu; Licata, Stephanie; Vonsy, Jean Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90:Issue 12(2019) Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis. (December 2021) Authors: Trojano, Maria; Ramió-Torrentà, Lluís; Grimaldi, Luigi ME; Lubetzki, Catherine; Schippling, Sven; Evans, Karleyton C; Ren, Zheng; Muralidharan, Kumar Kandadi; Licata, Stephanie; Gafson, Arie R Journal: Multiple sclerosis Issue: Volume 27:Number 14(2021) Page Start: 2240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP). (March 2021) Authors: Butzkueven, Helmut; Trojano, Maria; Kappos, Ludwig; Spelman, Tim; Wiendl, Heinz; Rosales, Karen; Su, Ray; Licata, Stephanie; Ho, Pei-Ran; Campbell, Nolan Journal: Multiple sclerosis Issue: Volume 27:Number 3(2021) Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP). Issue 6 (31st March 2020) Authors: Butzkueven, Helmut; Kappos, Ludwig; Wiendl, Heinz; Trojano, Maria; Spelman, Tim; Chang, Ih; Kasliwal, Rachna; Jaitly, Seema; Campbell, Nolan; Ho, Pei-Ran; Licata, Stephanie Other Names: author non-byline.; Abraham Roby author non-byline.; Adamkova Jana author non-byline.; Airas Laura author non-byline.; Aktas Orhan author non-byline.; Albrecht Holger author non-byline.; Alsassa Roger author non-byline.; de Arcaya Esquide Amaya Alvarez author non-byline.; Angstwurm Klemens autho... Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 91:Issue 6(2020) Page Start: 660 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study. Issue 10 (20th October 2020) Authors: Butzkueven, Helmut; Licata, Stephanie; Jeffery, Douglas; Arnold, Douglas L; Filippi, Massimo; Geurts, Jeroen JG; Santra, Sourav; Campbell, Nolan; Ho, Pei-Ran Journal: BMJ open Issue: Volume 10:Issue 10(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study. Issue 10 (20th October 2020) Authors: Butzkueven, Helmut; Licata, Stephanie; Jeffery, Douglas; Arnold, Douglas L; Filippi, Massimo; Geurts, Jeroen JG; Santra, Sourav; Campbell, Nolan; Ho, Pei-Ran Journal: BMJ open Issue: Volume 10:Issue 10(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗